# Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)

> **NCT01220752** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 36 (actual)

## Conditions studied

- Sinonasal Malignancies
- Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses

## Interventions

- **RADIATION:** carbon ion boost

## Key facts

- **NCT ID:** NCT01220752
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-17
- **Primary completion:** 2019-08-29
- **Final completion:** 2021-12-19
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220752, "Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01220752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*